Evidence map›Paper›PMID 31401763›Full record

ArticleFolia microbiologica2020

Dihydroisocoumarins produced by Diaporthe cf. heveae LGMF1631 inhibiting citrus pathogens.

Daiani Cristina Savi, Sandriele Aparecida Noriler, Larissa V Ponomareva, Jon S Thorson, Jürgen Rohr, Chirlei Glienke, Khaled A Shaaban

Open access · greenAbstract read
In one paragraph

Article in Folia microbiologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Antifungal Potential ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Daiani Cristina SaviDepartment of Genetics, Universidade Federal do Parana, Av. Coronel Francisco Heráclito dos Santos, 210, Curitiba, PR, 81531-970, Brazil.
Sandriele Aparecida NorilerDepartment of Pathology, Universidade Federal do Parana, Av. Coronel Francisco Heráclito dos Santos, 210, Curitiba, PR, 81531-970, Brazil.
Larissa V PonomarevaDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Kentuck, Lexington, KY, 40536, USA.
Jon S ThorsonDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Kentuck, Lexington, KY, 40536, USA.
Jürgen RohrDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Kentuck, Lexington, KY, 40536, USA.
Chirlei GlienkeDepartment of Genetics, Universidade Federal do Parana, Av. Coronel Francisco Heráclito dos Santos, 210, Curitiba, PR, 81531-970, Brazil. ch.glienke@gmail.com.
Khaled A ShaabanDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Kentuck, Lexington, KY, 40536, USA. khaled_shaaban@uky.edu.ORCID http://orcid.org/0000-0001-7638-4942
Universidade Federal do Paraná · BRUniversity of Kentucky · US

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
NOVEL AUREOLIC ACID TYPE ANTITUMOR AGENTSR01CA091901 · NCI · UNIVERSITY OF KENTUCKY · PI ROHR, JURGEN T · 2001 to 2017
$3.6M
Developing Regeneration Resources for a Model AmphibianR24OD021479 · OD · UNIVERSITY OF KENTUCKY · PI THORSON, JON SCOTT, VOSS, STEPHEN RANDAL · 2016 to 2019
$2.3M
Exploring Post-Type II PKS Frame ModificationsR01GM105977 · NIGMS · UNIVERSITY OF KENTUCKY · PI ROHR, JURGEN T · 2014 to 2017
$1.1M
Conselho Nacional de Desenvolvimento Científico e Tecnológico 309971/2016-0Conselho Nacional de Desenvolvimento Científico e Tecnológico 424738/2016-3NCATS NIH HHS UL1 TR000117NCATS NIH HHS UL1 TR001998NCI NIH HHS R01 CA091901NIGMS NIH HHS R01 GM105977NIH HHS CA 91091NIH HHS GM 105977NIH HHS R24 OD021479NIH HHS R24 OD21479
6 · The paper itself

Abstract

Citrus black spot (CBS) and post-bloom fruit drop (PFD), caused by Phyllosticta citricarpa and Colletotrichum abscissum, respectively, are two important citrus diseases worldwide. CBS depreciates the market value and prevents exportation of citrus fruits to Europe. PFD under favorable climatic conditions can cause the abscission of flowers, thereby reducing citrus production by 80%. An ecofriendly alternative to control plant diseases is the use of endophytic microorganisms, or secondary metabolites produced by them. Strain LGMF1631, close related to Diaporthe cf. heveae 1, was isolated from the medicinal plant Stryphnodendron adstringens and showed significant antimicrobial activity, in a previous study. In view of the potential presented by strain LGMF1631, and the absence of chemical data for secondary metabolites produced by D. cf. heveae, we decided to characterize the compounds produced by strain LGMF1631. Based on ITS, TEF1, and TUB phylogenetic analysis, strain LGMF1631 was confirmed to belong to D. cf. heveae 1. Chemical assessment of the fungal strain LGMF1631 revealed one new seco-dihydroisocoumarin [cladosporin B (1)] along with six other related, already known dihydroisocoumarin derivatives and one monoterpene [(-)-(1S,2R,3S,4R)-p-menthane-1,2,3-triol (8)]. Among the isolated metabolites, compound 5 drastically reduced the growth of both phytopathogens in vitro and completely inhibited the development of CBS and PFD in citrus fruits and flowers. In addition, compound 5 did not show toxicity against human cancer cell lines or citrus leaves, at concentrations higher than used for the inhibition of the phytopathogens, suggesting the potential use of (-)-(3R,4R)-cis-4-hydroxy-5-methylmellein (5) to control citrus diseases.

Indexed as

AscomycotaCitrusColletotrichumFabaceaeFruitFungicides, IndustrialIsocoumarinsPhylogenyPlant DiseasesPlant LeavesSaccharomycetalesFungicides, IndustrialIsocoumarins

Identifiers

PMID31401763
PMCPMC7017654
OpenAlexW2967949115

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.